|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03050138 |
|
Date of registration:
|
08/02/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran
DABI-PTS |
|
Scientific title:
|
The Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran- a Cross-Sectional Assessment of RE-COVER Study Patients |
|
Date of first enrolment:
|
April 2016 |
|
Target sample size:
|
351 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03050138 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Canada
|
Norway
|
Sweden
| | | | | |
|
Contacts
|
|
Name:
|
Hilde S Wik, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Oslo University Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Patients with DVT (±PE) treated in the RE-COVER studies.
2. Signed written informed consent.
Exclusion Criteria:
1. Patients who refuse to participate
2. Deceased patients
Age minimum:
N/A
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Postthrombotic Syndrome
|
|
Primary Outcome(s)
|
|
Post-thrombotic syndrome (PTS)
[Time Frame: April 2016 - December 2017]
|
|
Secondary Outcome(s)
|
|
Post-thrombotic syndrome (PTS) determined by the standard Villalta score
[Time Frame: April 2016 - December 2017]
|
|
Recurrent venous thromboembolism
[Time Frame: April 2016 - December 2017]
|
|
Disease specific health related Quality of Life (HRQoL)
[Time Frame: April 2016 - December 2017]
|
|
Generic health related Quality of Life (HRQoL)
[Time Frame: April 2016 - December 2017]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|